Inter-alpha-trypsin inhibitor heavy chain H3 is a potential biomarker for disease activity in myasthenia gravis.
Schroeter CB, Nelke C, Stascheit F, Huntemann N, Preusse C, Dobelmann V, Theissen L, Pawlitzki M, Räuber S, Willison A, Vogelsang A, Marina AD, Hartung HP, Melzer N, Konen FF, Skripuletz T, Hentschel A, König S, Schweizer M, Stühler K, Poschmann G, Roos A, Stenzel W, Meisel A, Meuth SG, Ruck T.
Schroeter CB, et al. Among authors: preusse c.
Acta Neuropathol. 2024 Jun 18;147(1):102. doi: 10.1007/s00401-024-02754-6.
Acta Neuropathol. 2024.
PMID: 38888758
Free PMC article.